2-chloro-n(6)cyclopentyladenosine has been researched along with Necrosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dacho, AK; Dietz, A; Mueller, K | 1 |
| Aust, G; Dacho, AK; Dietz, A; Lyutenski, S | 1 |
| Emala, CW; Lee, HT; Nasr, SH; Schnermann, J; Xu, H | 1 |
| Downey, JM; Olsson, RA; Thompson, R; Tsuchida, A | 1 |
4 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and Necrosis
| Article | Year |
|---|---|
Histological effect on the adipocutaneous flap in rats after preconditioning with 2-chloro-N(6) -cyclopentyladenosine.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adipose Tissue; Animals; Ischemic Preconditioning; Male; Necrosis; Rats; Rats, Wistar; Reperfusion Injury; Skin; Surgical Flaps | 2014 |
Highly selective A(1) -adenosine-agonist (2-chloro-N6-cyclopentyladenosine) and reduction of flap necrosis in adipocutaneous flaps in rats.
Topics: Adenosine; Animals; Catheterization, Central Venous; Infusions, Intravenous; Male; Necrosis; Rats; Rats, Wistar; Reperfusion Injury; Surgical Flaps; Vasodilator Agents | 2012 |
A1 adenosine receptor knockout mice exhibit increased renal injury following ischemia and reperfusion.
Topics: Acute Kidney Injury; Adenosine; Adenosine A1 Receptor Antagonists; Animals; Apoptosis; Biomarkers; Genotype; In Situ Nick-End Labeling; Intercellular Adhesion Molecule-1; Interleukin-1; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Necrosis; Neutrophils; Receptor, Adenosine A1; Reperfusion Injury; RNA, Messenger; Tumor Necrosis Factor-alpha; Xanthines | 2004 |
The anti-infarct effect of an adenosine A1-selective agonist is diminished after prolonged infusion as is the cardioprotective effect of ischaemic preconditioning in rabbit heart.
Topics: Acetylcholine; Adenosine; Animals; Bradycardia; Drug Tolerance; Female; Hemodynamics; Hypotension; Infusions, Intravenous; Male; Muscle Proteins; Myocardial Infarction; Myocardial Ischemia; Myocardium; Necrosis; Purinergic P1 Receptor Antagonists; Rabbits; Receptors, Muscarinic; Receptors, Purinergic P1 | 1994 |